Furthermore, the increased expression of Cdx2, and other differentiation-driving transcription factors like Klf4 and the WNT antagonist, Ndrg1, in BLM tumors push the tumor stem cells toward the various differentiated lineages (Supplemental Figure S6E). This evidence concerns the gene CDX2 and neoplasm.